RETRACTED: miR-34 increases in vitro PANC-1 cell sensitivity to gemcitabine via targeting Slug/PUMA

Article type: Research Article

Authors: Zhang, Qing-An^{a; 1} | Yang, Xu-Hai^f | Chen, Dong^c | Yan, Xiang^b | Jing, Fu-Chun^{d; *} | Liu, Hong-Qian^e | Zhang, Ronghua^a

Affiliations: [a] Department of Clinical Laboratory, The Central Hospital of Linyi, Yishui, Shandong, China | [b] Department of Oncology, Yantaiyuhuangding Hospital, Yantai, Shandong, China | [c] Department of General Surgery, The Affiliated Hospital of Qingdao University, Qingdao,Shandong, China | [d] Department of Gastroenterology, Taian Central Hospital, Taian, Shandong, China | [e] Department Pharmacy, The Central Hospital of Linyi, Yishui, Shandong, China | [f] Department of Hemopurification Center, Yantaiyuhuangding Hospital, Yantai, Shandong, China

Correspondence: [*] Corresponding author: Fuchun Jing, Department of Gastroenterology, Taian Central Hospital, Taian, Shandong, China. E-mail: [email protected].

Note: [1] These authors contributed equally to the work.

Abstract: This article has been retracted, and the online PDF has been watermarked “RETRACTION”. The retraction notice is available at http://doi.org/10.3233/CBM219903

Keywords: Pancreatic cancer, chemoresistance, miR-34, Slug, PUMA

DOI: 10.3233/CBM-170289

Journal: Cancer Biomarkers, vol. 21, no. 4, pp. 755-762, 2018